Side Effects and Safety Concerns of Flibanserin

Female pleasure outside those boundaries is framed as indulgent, destabilizing, even sinful. Throughout history, many religious doctrines have treated women’s sexuality as something to regulate. Modesty codes, purity culture, and rigid gender roles are not fringe ideas. They are embedded in institutions that shape law and policy. The recent rise of right-leaning political movements has amplified these frameworks.

Why did Sprout have to file a separate request to treat decreased libido in women past menopause?

And those were not the same considerations for women.” (The FDA, which denied any accusations of gender bias, did not respond to the film-makers’ interview requests. “I will give the benefit of the doubt to the FDA that they were in the midst of like getting Doge-ed,” Chin-Yee said, referring to the Elon Musk-led consolidation that gutted the department.) Never mind that many women wanted their desire back, and felt less whole without it. “I thought ‘well, after you have kids, that goes away …’” says one HSDD patient in the film, frustrated by her lack of options and a prevailing narrative that “you’re a mother now and you focus on these things. That’s behind you.” The loss of sexual desire was “devastating”, says another whose menopause torched her formerly steady libido. “I felt like someone had slayed me.” Both Gattuso and her daughter testified at the FDA’s public hearing on the drug’s approval, speaking emotionally about the toll their diminished libido had taken on their lives.

What are the serious side effects of Addyi?

Opponents of the drug put the onus back on them; one recommended they instead try what worked for her: “switching boyfriends, chocolate, coffee, certain episodes of Grey’s Anatomy, pornography, upgrading my vibrator, read Fifty Shades of Grey, a removable shower-head and an acceptance of myself and the libido I came with”. After much heated back and forth, the FDA approved Addyi in 2015. Eckert subsequently sold Sprout to pharma giant Valeant for $1bn. But the victory came with a major caveat: a black box warning, the most serious level available, for side effects such as dizziness, nausea and headache. Doctors had to take a test to prescribe it. The idealized “tradwife” narrative celebrates domestic submission, childbearing, and withdrawal from public power.

Against that backdrop, a drug designed to enhance female desire becomes more than medicine.

i have little to no sexual desire

There are 26 drugs approved for male sexual dysfunction, Chin-Yee noted, in part because no drug fits all. “That’s obvious, but for this drug and for women, it’s like, ‘well, if this could be a potential side effect, then the risk isn’t worth the benefit,’” she said. “And the benefit is only that women might enjoy their sex better. You know how many drugs come with nausea and dizziness and headaches? Those are things that pretty much every drug has on the side of their box.” The through line, she emphasized, is choice.

What are the most common side effects of Addyi?

“You should be able to have that discussion with your own body and your own physician, rather than somebody just removing it as an option for you.” The film puts that pursuit of pleasure in context with a very different medical landscape than when Addyi first premiered, a post-Roe world in which women’s reproductive rights are under assault, healthcare for trans people is criminalized and bodily autonomy across the board remains tenuous. Whether for abortion or orgasm, there’s nothing diminutive or inconsequential about choice, the film concludes. “You might think it’s funny and frivolous to say that women enjoying sex with their husbands is necessary,” said Chin-Yee. “But it is exactly that right being taken away that is related to all the other rights that could be taken away from you, and are being removed in the United States right now.” The Pink Pill is now available on Paramount+ The Pink Pill is now available on Paramount+ There is a reason the fight over a small pink pill feels so enormous. On its surface, The Pink Pill: Sex, Drugs & Who Has Control chronicles the battle to bring a medication for women’s low sexual desire to market. The Pink Pill makes clear that resistance to Addyi was not solely about clinical data.

• Pink pills are sometimes associated with the "pink economy" in sexual health.
• They are popular among women seeking discreet, quick solutions.
• Not all pink pills are evidence-based; some rely heavily on marketing claims.
• Consulting a healthcare professional is essential before starting any supplement.

Discomfort with the idea that women might seek sex for pleasure rather than obligation. Discomfort with acknowledging that female libido is not automatically extinguished by age, motherhood, or long-term partnership.

• The pink pill targets issues like low desire and menstrual discomfort.
• It may improve mood and increase energy levels in women.
• Side effects can include headaches, nausea, or hormonal imbalances.
• Its use is often personalized based on hormonal levels and health status.

Discomfort with women naming dissatisfaction and demanding solutions. Fear sits at the center of this discomfort.

Is Addyi effective?

The film shows regulators raising concerns that women might become drowsy and fall asleep while driving children to school. The subtext is unmistakable: a vardenafil pills woman’s primary role is caretaker. Her pleasure is secondary and deeply suspect. What makes the documentary especially urgent is its timing. Chin-Yee situates Eckert’s fight within a broader political shift. Fear that sexual agency disrupts traditional hierarchies. Fear that a woman who claims her own pleasure might also claim her own economic and political independence. Fear that equality in the bedroom signals equality everywhere. Outspoken and unapologetic in her trademark pink, she confronts regulators and critics head-on. She marshals advocacy groups and public pressure to expose, as she frames it, gender bias at the FDA. When Addyi finally won approval in 2015, the victory felt seismic.

It is proof that persistence can pierce institutional inertia. Yet the film does not end in triumph alone. It shows how the drug’s subsequent corporate handling undercut accessibility, how political shifts darkened the broader landscape of rights, and how the battle for bodily autonomy is never isolated. Reproductive freedom, sexual health, workplace equality, and economic independence are interconnected. Chin-Yee expands the narrative beyond Eckert. Doctors and scientists challenge the long-standing dismissal of female hypoactive sexual desire disorder.

THR Newsletters

Male sexual performance is framed as essential to identity. If a man cannot perform, it is treated as a crisis of masculinity and a medical emergency. If a woman cannot orgasm, feels pain during intercourse, or loses desire, she is told it is normal. It exposes how medical education and healthcare institutions have long sidelined women’s sexual needs. These same systems have aggressively funded and fast-tracked drugs for men. Women speak candidly about losing libido and feeling erased.

I feel stressed due to my low desire

Pharmacists had to take a test to fill it. Women prescribed Addyi had to sign a pledge that they would not drink alcohol. (Viagra, on the other hand, came with a recommendation that one merely should avoid alcohol.) Faced with declining sales, Valeant more than doubled the price of Addyi, to $800 a prescription, making the drug cost-prohibitive. Then, in 2017, they shelved it altogether. What had once been the promising frontier in female sexual health was now essentially locked away.

Does Addyi interact with other medicines (drug interactions)?

“How can you possibly pass something that is so wonderful for women and then have it ripped out?” says Gattuso in the film. “After all of this work, all of this emotion, we’re down to square one again. Eckert managed to buy Addyi back from Valeant and start over. The drug is back on the market – though, if you google it, the first thing you will read is still a bold warning about side effects. Addyi proponents see a seriously stubborn double standard. Their testimonies are radical precisely because they are ordinary. Critics who argue that HSDD is over-medicalized appear as well. Instead, it asks who historically has had the authority to define women’s experiences as real or fabricated.

• Some pink pills combine herbal extracts like ginseng or maca for effects.
• They are popular in wellness circles for enhancing intimacy and confidence.
• Research on pink pills' long-term safety is limited; caution is advised.
• Available through online stores, pharmacies, or clinics in some regions.

Too often, that authority has rested in male-dominated institutions shaped by cultural and religious norms that prize control over autonomy. The film’s core message is direct: Female pleasure is fundamental to health, dignity, and equality, not a trivial matter. When political leaders legislate reproductive limits and religious authorities preach submission, the underlying logic is similar. Women’s bodies are communal property to be governed, not individual domains to be inhabited.

The Big Pink Fight for the Little Pink Pill

Footage of the 2016 election, the reshaping of the Supreme Court, and the fall of Roe v Wade is not incidental. As the political right has gained power, reproductive rights have narrowed. Conversations about contraception and bodily autonomy have become battlegrounds. Movements that seek to limit women’s control over reproduction often also resist conversations about female desire. In conservative and religious circles, sexuality is frequently tethered to procreation and marriage. The Pink Pill exposes how that logic infiltrates science, medicine, and law.

Why do you think sexual desire in women is not treated seriously by the medical community?

At its core, the documentary is about power. It is about who gets to define health, who gets to claim pleasure, and who benefits when women are told to stay quiet about their bodies. Women all wonder, “What happened to me?” Men always get listened to. Women are dismissed and made to feel wrong for even asking the question. Directed by Aisling Chin-Yee and premiering at DOC NYC, the film follows entrepreneur Cindy Eckert’s decade-long struggle to win FDA approval for Addyi, the drug frequently labeled “female Viagra.” The nickname is catchy.

Drug information

More than twenty medications for male erectile dysfunction have been approved with relative efficiency. Addyi was stalled, scrutinized, and moralized for years. Why do we want horny women running around? You want to throttle the lot as you watch. From the beginning, the film establishes the central injustice. It shows how breakthroughs in understanding female sexual response are met not just with skepticism but with attempts to contain them. In illuminating these patterns, the film becomes more than a chronicle of one drug. Gains in gender equity are not guaranteed. They can be reframed as threats to social order. Witty, incisive, and unapologetically provocative, The Pink Pill demands that viewers confront the hypocrisy of a culture that celebrates male virility while policing female desire. It challenges the rising chorus of voices that seek to return women to narrower roles under the banner of tradition or faith.

• The term "pink pill" is often used metaphorically for gender-specific health solutions.
• Ongoing research aims to develop more effective, safe female libido enhancers.
• Cultural acceptance of such pills varies globally, affecting accessibility.
• Awareness about female sexual health continues to grow, driving demand.